Deferoxamine
AlkaPlorer ID: AK002738
Synonym: N'-[5-[[4-[[5-(Acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]-N-(5-aminopentyl)-N-hydroxybutanediamide, Desferrioxamine B, Desferrioxamine, Desferrin, NSC 527604
IUPAC Name: N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N'-(5-aminopentyl)-N'-hydroxybutanediamide
Structure
SMILES: CC(=O)N(O)CCCCCN=C(O)CCC(=O)N(O)CCCCCN=C(O)CCC(=O)N(O)CCCCCN
InChI: InChI=1S/C25H48N6O8/c1-21(32)29(37)18-9-3-6-16-27-22(33)12-14-25(36)31(39)20-10-4-7-17-28-23(34)11-13-24(35)30(38)19-8-2-5-15-26/h37-39H,2-20,26H2,1H3,(H,27,33)(H,28,34)
InChIKey: UBQYURCVBFRUQT-UHFFFAOYSA-N
Reference
PubChem CID: 129894466
CAS: ng
LOTUS: LTS0267339
NPASS: NPC262615
COCONUT: CNP0336264
{NPAtlas: NPA009012
Source
Properties Information
Molecule Weight: 560.6930000000002
TPSA?: 212.82
MolLogP?: 2.6027000000000013
Number of H-Donors: 6
Number of H-Acceptors: 9
RingCount: 0
Activities Information
| Organism | Target Name | Standard Type | Standard Value | Standard Units | doi |
|---|---|---|---|---|---|
| Agaricus bisporus | Tyrosinase | Inhibition | nan | % | 10.1021/jm401053m |
| Canis lupus familiaris | MDCK | IC50 | 9490.0 | nM | 10.1021/jm9016703 |
| Cercopithecidae | Monkey | Efficiency | 0.1 | % | 10.1021/jm020184n |
| Cercopithecidae | Monkey | Efficiency | 5.5 | % | 10.1021/jm020184n |
| Cercopithecidae | Monkey | Urine/bile | nan | None | 10.1021/jm020184n |
| Chlamydia trachomatis | Chlamydia trachomatis | GI | nan | None | 10.1016/j.bmcl.2014.06.056 |
| Escherichia coli | Escherichia coli | Activity | 38.0 | None | 10.1021/jm010546b |
| Homo sapiens | A2780 | IC50 | 3500.0 | nM | 10.1021/acsmedchemlett.2c00250 |
| Homo sapiens | A549 | IC50 | 7500.0 | nM | 10.1021/jm300768u |
| Homo sapiens | A549 | Inhibition | 2.0 | % | 10.1016/j.bmc.2009.11.057 |
| Homo sapiens | A549 | Inhibition | 50.0 | % | 10.1016/j.bmc.2009.11.057 |
| Homo sapiens | Carbonic anhydrase II | Inhibition | nan | % | 10.1021/jm401053m |
| Homo sapiens | CHP-126 | Activity | 80.0 | % | 10.1021/jm900552r |
| Homo sapiens | Cytochrome P450 2C9 | FC | 1.0 | None | 10.1016/j.bmcl.2016.06.088 |
| Homo sapiens | Cytochrome P450 2D6 | FC | 1.0 | None | 10.1016/j.bmcl.2016.06.088 |
| Homo sapiens | Cytochrome P450 3A4 | FC | 1.0 | None | 10.1016/j.bmcl.2016.06.088 |
| Homo sapiens | Deoxyhypusine hydroxylase | IC50 | 5000.0 | nM | 10.1016/j.ejmech.2019.01.018 |
| Homo sapiens | DLD-1 | IC50 | 2900.0 | nM | 10.1016/j.ejmech.2020.113149 |
| Homo sapiens | DMS-53 | IC50 | 10000.0 | nM | 10.1021/jm300768u |
| Homo sapiens | DNA polymerase iota | Potency | 31622.8 | nM | None |
| Homo sapiens | DNA topoisomerase II alpha | Inhibition | nan | % | 10.1021/jm9014394 |
| Homo sapiens | Geminin | Potency | 145.8 | nM | None |
| Homo sapiens | Guanine nucleotide-binding protein G(s), subunit alpha | Potency | 44668.4 | nM | None |
| Homo sapiens | HCT-116 | Activity | nan | None | 10.1021/ml400422a |
| Homo sapiens | HCT-116 | CI | 1.01 | None | 10.1021/ml400422a |
| Homo sapiens | HCT-116 | IC50 | 200000.0 | nM | 10.1021/ml400422a |
| Homo sapiens | HCT-116 | Inhibition | 0.0 | % | 10.1016/j.bmc.2009.11.057 |
| Homo sapiens | HCT-116 | Inhibition | 20.0 | % | 10.1016/j.bmc.2009.11.057 |
| Homo sapiens | HCT-15 | Inhibition | 0.0 | % | 10.1016/j.bmc.2009.11.057 |
| Homo sapiens | HCT-15 | Inhibition | 46.0 | % | 10.1016/j.bmc.2009.11.057 |
| Homo sapiens | HeLa | IC50 | 50000.0 | nM | 10.1021/jm701307j |
| Homo sapiens | HeLa | IC50 | nan | None | 10.1021/ml400422a |
| Homo sapiens | Hepatocyte | Activity | 162.0 | % | 10.1016/j.bmc.2009.11.057 |
| Homo sapiens | HepG2 | IC50 | 100000.0 | nM | 10.1016/j.bmcl.2017.11.048 |
| Homo sapiens | HepG2 | Inhibition | 0.0 | % | 10.1016/j.bmc.2009.11.057 |
| Homo sapiens | HepG2 | Inhibition | 40.0 | % | 10.1016/j.bmcl.2017.11.048 |
| Homo sapiens | HepG2 | Inhibition | nan | % | 10.1016/j.bmcl.2017.11.048 |
| Homo sapiens | HepG2 | Potency | 5623.4 | nM | None |
| Homo sapiens | Histone deacetylase 2 | Inhibition | nan | % | 10.1021/jm401053m |
| Homo sapiens | Histone deacetylase 6 | Inhibition | -10.89 | % | 10.6019/CHEMBL4808148 |
| Homo sapiens | Histone deacetylase 6 | Inhibition | -4.71 | % | 10.6019/CHEMBL4808148 |
| Homo sapiens | HL-60 | GI50 | 18400.0 | nM | 10.1016/j.bmc.2012.11.009 |
| Homo sapiens | HL-60 | Inhibition | 0.0 | % | 10.1016/j.bmc.2009.11.057 |
| Homo sapiens | Homo sapiens | % absorbed | 2.0 | % | 10.1021/jm001020e |
| Homo sapiens | Homo sapiens | DILI_Concern | nan | None | 10.1016/j.drudis.2016.02.015 |
| Homo sapiens | Homo sapiens | DILI_severity_class | 0.0 | None | 10.1016/j.drudis.2016.02.015 |
| Homo sapiens | HT-29 | Activity | nan | None | 10.1021/jm9014394 |
| Homo sapiens | HT-29 | IC50 | 36100.0 | nM | 10.1021/jm701307j |
| Homo sapiens | HT-29 | Inhibition | 0.0 | % | 10.1016/j.bmc.2009.11.057 |
| Homo sapiens | HT-29 | Inhibition | 42.0 | % | 10.1016/j.bmc.2009.11.057 |
| Homo sapiens | Hypoxia-inducible factor 1 alpha | EC50 | 17800.0 | nM | 10.1016/j.bmcl.2011.11.077 |
| Homo sapiens | Isocitrate dehydrogenase [NADP] cytoplasmic | Potency | 9200.0 | nM | None |
| Homo sapiens | K562 | GI50 | 33100.0 | nM | 10.1016/j.bmc.2012.11.009 |
| Homo sapiens | K562 | Inhibition | 0.0 | % | 10.1016/j.bmc.2009.11.057 |
| Homo sapiens | KB | Inhibition | 0.0 | % | 10.1016/j.bmc.2009.11.057 |
| Homo sapiens | KB | Inhibition | 16.0 | % | 10.1016/j.bmc.2009.11.057 |
| Homo sapiens | L02 | Activity | nan | None | 10.1016/j.bmcl.2017.11.048 |
| Homo sapiens | Lysine-specific demethylase 4A | IC50 | 3220.0 | nM | 10.1021/acs.jmedchem.2c00680 |
| Homo sapiens | Lysine-specific demethylase 4A | IC50 | 3330.0 | nM | 10.1021/acs.jmedchem.2c00680 |
| Homo sapiens | Matrix metalloproteinase 12 | Inhibition | nan | % | 10.1021/jm401053m |
| Homo sapiens | Matrix metalloproteinase-2 | Inhibition | nan | % | 10.1021/jm401053m |
| Homo sapiens | MCF7 | Inhibition | 0.0 | % | 10.1016/j.bmc.2009.11.057 |
| Homo sapiens | MCF7 | Inhibition | 9.0 | % | 10.1016/j.bmc.2009.11.057 |
| Homo sapiens | MDA-MB-231 | IC50 | 6100.0 | nM | 10.1021/acsmedchemlett.2c00250 |
| Homo sapiens | Methylcytosine dioxygenase TET2 | IC50 | 46000.0 | nM | 10.1039/d2md00186a |
| Homo sapiens | MRC5 | IC50 | 9000.0 | nM | 10.1021/acsmedchemlett.2c00250 |
| Homo sapiens | MRC5 | IC50 | 10000.0 | nM | 10.1021/jm300768u |
| Homo sapiens | Neutrophil | Activity | nan | None | 10.1021/acsmedchemlett.9b00142 |
| Homo sapiens | Neutrophil | Inhibition | nan | % | 10.1021/acsmedchemlett.9b00142 |
| Homo sapiens | NHDF | IC50 | nan | None | 10.1021/ml400422a |
| Homo sapiens | Nuclear factor erythroid 2-related factor 2 | Potency | 14581.0 | nM | None |
| Homo sapiens | PC-3 | Inhibition | 1.0 | % | 10.1016/j.bmc.2009.11.057 |
| Homo sapiens | PC-3 | Inhibition | 44.0 | % | 10.1016/j.bmc.2009.11.057 |
| Homo sapiens | Raji | IC50 | nan | None | 10.1021/ml400422a |
| Homo sapiens | Serotransferrin | Activity | 4.0 | % | 10.1021/jm801585u |
| Homo sapiens | Serotransferrin | Activity | 5.0 | % | 10.1021/jm00069a002 |
| Homo sapiens | Serotransferrin | Activity | 14.2 | % | 10.1021/jm801585u |
| Homo sapiens | Serotransferrin | Fe removed | 5.0 | % | 10.1021/jm00357a022 |
| Homo sapiens | Serotransferrin | Inhibition | 87.0 | % | 10.1021/jm9016703 |
| Homo sapiens | Serotransferrin | Inhibition | 94.0 | % | 10.1021/jm7012562 |
| Homo sapiens | Serotransferrin | K | 0.0 | 10'2/min | 10.1021/jm401053m |
| Homo sapiens | SF-268 | Inhibition | 0.0 | % | 10.1016/j.bmc.2009.11.057 |
| Homo sapiens | SF-268 | Inhibition | 33.0 | % | 10.1016/j.bmc.2009.11.057 |
| Homo sapiens | SH-SY5Y | Activity | 76.0 | % | 10.1021/jm070800l |
| Homo sapiens | SH-SY5Y | Activity | 77.4 | % | 10.1016/j.ejmech.2021.113168 |
| Homo sapiens | SH-SY5Y | Activity | 79.5 | % | 10.1016/j.ejmech.2021.113168 |
| Homo sapiens | SH-SY5Y | Activity | 87.2 | % | 10.1016/j.ejmech.2021.113168 |
| Homo sapiens | SH-SY5Y | Inhibition | nan | % | 10.1016/j.ejmech.2021.113168 |
| Homo sapiens | SK-N-BE(2)-M17 | Activity | nan | None | 10.1016/j.bmcl.2017.03.001 |
| Homo sapiens | SK-N-BE(2)-M17 | EC50 | nan | None | 10.1016/j.bmcl.2017.03.001 |
| Homo sapiens | SK-N-MC | Activity | 1.0 | % | 10.1021/jm070839q |
| Homo sapiens | SK-N-MC | Activity | 7.0 | % | 10.1021/jm070445z |
| Homo sapiens | SK-N-MC | Activity | 12.0 | % | 10.1021/jm301691s |
| Homo sapiens | SK-N-MC | Activity | 12.0 | % | 10.1021/jm9016703 |
| Homo sapiens | SK-N-MC | Activity | 13.0 | % | 10.1021/jm801585u |
| Homo sapiens | SK-N-MC | Activity | 15.2 | % | 10.1021/jm300768u |
| Homo sapiens | SK-N-MC | Activity | 23.0 | % | 10.1021/jm200924c |
| Homo sapiens | SK-N-MC | Activity | 77.0 | % | 10.1021/jm301691s |
| Homo sapiens | SK-N-MC | Activity | 80.0 | % | 10.1016/j.bmcl.2012.12.044 |
| Homo sapiens | SK-N-MC | Activity | 84.0 | % | 10.1021/jm300768u |
| Homo sapiens | SK-N-MC | Activity | 89.0 | % | 10.1016/j.ejmech.2017.08.021 |
| Homo sapiens | SK-N-MC | Activity | 99.0 | % | 10.1021/jm200924c |
| Homo sapiens | SK-N-MC | Activity | nan | None | 10.1016/j.ejmech.2017.08.021 |
| Homo sapiens | SK-N-MC | IC50 | 4510.0 | nM | 10.1021/jm070445z |
| Homo sapiens | SK-N-MC | IC50 | 5000.0 | nM | 10.1021/jm900552r |
| Homo sapiens | SK-N-MC | IC50 | 7350.0 | nM | 10.1021/jm801585u |
| Homo sapiens | SK-N-MC | IC50 | 8580.0 | nM | 10.1021/jm0606342 |
| Homo sapiens | SK-N-MC | IC50 | 9890.0 | nM | 10.1016/j.bmc.2010.02.025 |
| Homo sapiens | SK-N-MC | IC50 | 10000.0 | nM | 10.1021/jm300768u |
| Homo sapiens | SK-N-MC | IC50 | 12500.0 | nM | 10.1016/j.bmcl.2012.07.030 |
| Homo sapiens | SK-N-MC | IC50 | 14220.0 | nM | 10.1021/jm070839q |
| Homo sapiens | SK-N-MC | IC50 | 16040.0 | nM | 10.1021/jm9016703 |
| Homo sapiens | SK-N-MC | IC50 | 16810.0 | nM | 10.1016/j.ejmech.2017.08.021 |
| Homo sapiens | SK-N-MC | IC50 | 17070.0 | nM | 10.1016/j.bmc.2010.10.025 |
| Homo sapiens | SK-N-MC | IC50 | 17070.0 | nM | 10.1016/j.bmc.2011.11.033 |
| Homo sapiens | SK-N-MC | IC50 | 21630.0 | nM | 10.1016/j.bmcl.2012.12.044 |
| Homo sapiens | SK-N-MC | IC50 | 22000.0 | nM | 10.1021/jm900552r |
| Homo sapiens | SK-N-MC | IC50 | 22700.0 | nM | 10.1021/jm200924c |
| Homo sapiens | SK-N-MC | IC50 | 22700.0 | nM | 10.1021/jm301691s |
| Homo sapiens | SK-N-MC | Inhibition | 8.0 | % | 10.1021/jm070839q |
| Homo sapiens | SK-N-MC | Inhibition | 74.0 | % | 10.1021/jm200924c |
| Homo sapiens | SK-OV-3 | Inhibition | 5.0 | % | 10.1016/j.bmc.2009.11.057 |
| Homo sapiens | SK-OV-3 | Inhibition | 52.0 | % | 10.1016/j.bmc.2009.11.057 |
| Homo sapiens | SMMC-7721 | Activity | 5.0 | % | 10.1016/j.ejmech.2015.07.040 |
| Homo sapiens | SW480 | IC50 | 3800.0 | nM | 10.1016/j.ejmech.2020.113149 |
| Homo sapiens | Trypsin | Inhibition | nan | % | 10.1021/jm401053m |
| Homo sapiens | Tyrosyl-DNA phosphodiesterase 1 | Potency | 11582.1 | nM | None |
| Homo sapiens | Tyrosyl-DNA phosphodiesterase 1 | Potency | 20596.2 | nM | None |
| Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Activity | nan | None | 10.1016/j.bmc.2013.08.023 |
| Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | EC50 | 384000.0 | nM | 10.1016/j.bmc.2013.08.023 |
| Leishmania infantum | Leishmania infantum | GI50 | 150000.0 | nM | 10.1016/j.bmc.2012.11.009 |
| Mus musculus | Mus musculus | Activity | 3.0 | ug | 10.1021/jm00197a007 |
| Mus musculus | Mus musculus | Activity | 9.4 | ug | 10.1021/jm00197a007 |
| Mus musculus | Mus musculus | Activity | 16.4 | ug | 10.1021/jm00197a007 |
| Mus musculus | Mus musculus | Activity | 19.2 | ug | 10.1021/jm00197a007 |
| Mus musculus | Mus musculus | Activity | 75.0 | % | 10.1021/jm00197a007 |
| Mus musculus | Mus musculus | Activity | 132.0 | ug | 10.1021/jm00197a007 |
| Mus musculus | Mus musculus | Iron change | -24.0 | % | 10.1021/jm00157a020 |
| Mus musculus | Mus musculus | Iron change | 2.0 | % | 10.1021/jm00157a020 |
| Mus musculus | Mus musculus | Iron change | 7.0 | % | 10.1021/jm00157a020 |
| Mus musculus | Mus musculus | Iron change | 270.0 | % | 10.1021/jm00157a020 |
| Mus musculus | Mus musculus | No. of survivors | 240.0 | None | 10.1021/jm00157a020 |
| Mus musculus | NIH3T3 | IC50 | 4900.0 | nM | 10.1021/acsmedchemlett.9b00142 |
| Mus musculus | NIH3T3 | IC50 | 9000.0 | nM | 10.1021/acsmedchemlett.9b00142 |
| Mycobacterium avium | Mycobacterium avium | Growth Index | 1.09 | None | 10.1021/jm049805y |
| Mycobacterium avium subsp. paratuberculosis | Mycobacterium avium subsp. paratuberculosis | GI | 0.92 | None | 10.1021/jm0104522 |
| Plasmodium falciparum | Plasmodium falciparum | GI50 | 28000.0 | nM | 10.1016/j.bmc.2012.11.009 |
| Plasmodium falciparum | Plasmodium falciparum | IC50 | 3400.0 | nM | 10.1021/jm201095h |
| Plasmodium yoelii | Plasmodium yoelii | IC50 | 20000.0 | nM | 10.1021/jm201095h |
| Pseudomonas aeruginosa | Pseudomonas aeruginosa | Activity | 30.0 | None | 10.1021/jm010546b |
| Pseudomonas aeruginosa | Pseudomonas aeruginosa | Activity | 36.0 | None | 10.1021/jm010546b |
| Rattus norvegicus | Brain | Activity | nan | None | 10.1021/jm070800l |
| Rattus norvegicus | Brain | Inhibition | 72.0 | % | 10.1021/jm070398a |
| Rattus norvegicus | Rattus norvegicus | Activity | 2.5 | % | 10.1016/j.bmc.2015.06.059 |
| Rattus norvegicus | Rattus norvegicus | Activity | 26.0 | % | 10.1016/j.bmc.2015.06.059 |
| Rattus norvegicus | Rattus norvegicus | Activity | 74.0 | % | 10.1016/j.bmc.2015.06.059 |
| Rattus norvegicus | Rattus norvegicus | Distribution | 0.08 | % | 10.1021/jm00356a037 |
| Rattus norvegicus | Rattus norvegicus | Distribution | 0.2 | % | 10.1021/jm00356a037 |
| Rattus norvegicus | Rattus norvegicus | Distribution | 0.3 | % | 10.1021/jm00356a037 |
| Rattus norvegicus | Rattus norvegicus | Distribution | 0.4 | % | 10.1021/jm00356a037 |
| Rattus norvegicus | Rattus norvegicus | Distribution | 0.6 | % | 10.1021/jm00356a037 |
| Rattus norvegicus | Rattus norvegicus | Distribution | 1.8 | % | 10.1021/jm00356a037 |
| Rattus norvegicus | Rattus norvegicus | Distribution | 3.0 | % | 10.1021/jm00356a037 |
| Rattus norvegicus | Rattus norvegicus | Distribution | 7.4 | % | 10.1021/jm00356a037 |
| Rattus norvegicus | Rattus norvegicus | Distribution | 15.5 | % | 10.1021/jm00356a037 |
| Rattus norvegicus | Rattus norvegicus | Distribution | 18.7 | % | 10.1021/jm00356a037 |
| Rattus norvegicus | Rattus norvegicus | Distribution | 62.9 | % | 10.1021/jm00356a037 |
| Rattus norvegicus | Rattus norvegicus | Distribution | 71.3 | % | 10.1021/jm00356a037 |
| Rattus norvegicus | Rattus norvegicus | Efficiency | 1.0 | % | 10.1021/jm00036a005 |
| Rattus norvegicus | Rattus norvegicus | Efficiency | 1.1 | % | 10.1021/jm020184n |
| Rattus norvegicus | Rattus norvegicus | Efficiency | 2.8 | % | 10.1021/jm00036a005 |
| Rattus norvegicus | Rattus norvegicus | Efficiency | 2.8 | % | 10.1021/jm020184n |
| Rattus norvegicus | Rattus norvegicus | IC50 | 112000.0 | nM | 10.1021/jm00166a010 |
| Rattus norvegicus | Rattus norvegicus | Iron clearence | 86.0 | ug kg-1 | 10.1021/jm00036a005 |
| Rattus norvegicus | Rattus norvegicus | Iron clearence | 232.0 | ug kg-1 | 10.1021/jm00036a005 |
| Rattus norvegicus | Rattus norvegicus | Iron excretion | 0.059 | mg kg-1 | 10.1021/jm00103a012 |
| Rattus norvegicus | Rattus norvegicus | Iron excretion | 0.173 | mg kg-1 | 10.1021/jm00103a012 |
| Rattus norvegicus | Rattus norvegicus | Iron excretion | 0.232 | mg kg-1 | 10.1021/jm00103a012 |
| Rattus norvegicus | Rattus norvegicus | Iron excretion | 2.8 | % | 10.1021/jm00103a012 |
| Rattus norvegicus | Rattus norvegicus | Iron excretion | 25.4 | % | 10.1021/jm00103a012 |
| Rattus norvegicus | Rattus norvegicus | Iron excretion | 74.6 | % | 10.1021/jm00103a012 |
| Rattus norvegicus | Rattus norvegicus | Iron output | 14.7 | None | 10.1021/jm00115a006 |
| Rattus norvegicus | Rattus norvegicus | Iron output | 16.5 | None | 10.1021/jm00115a006 |
| Rattus norvegicus | Rattus norvegicus | Iron output | 43.6 | None | 10.1021/jm00115a006 |
| Rattus norvegicus | Rattus norvegicus | Iron output | 43.9 | None | 10.1021/jm00115a006 |
| Rattus norvegicus | Rattus norvegicus | Iron output | 49.2 | None | 10.1021/jm00115a006 |
| Rattus norvegicus | Rattus norvegicus | Iron output | 76.8 | None | 10.1021/jm00115a006 |
| Rattus norvegicus | Rattus norvegicus | Iron output | 86.3 | None | 10.1021/jm00115a006 |
| Rattus norvegicus | Rattus norvegicus | Iron output | 97.1 | None | 10.1021/jm00115a006 |
| Rattus norvegicus | Rattus norvegicus | Iron output | 105.9 | None | 10.1021/jm00115a006 |
| Rattus norvegicus | Rattus norvegicus | Iron output | 110.8 | None | 10.1021/jm00115a006 |
| Rattus norvegicus | Rattus norvegicus | Iron output | 119.8 | None | 10.1021/jm00115a006 |
| Rattus norvegicus | Rattus norvegicus | Iron output | 128.7 | None | 10.1021/jm00115a006 |
| Rattus norvegicus | Rattus norvegicus | Iron output | 135.0 | None | 10.1021/jm00115a006 |
| Rattus norvegicus | Rattus norvegicus | Iron output | 151.5 | None | 10.1021/jm00115a006 |
| Rattus norvegicus | Rattus norvegicus | Iron output | 152.8 | None | 10.1021/jm00115a006 |
| Rattus norvegicus | Rattus norvegicus | Iron output | 173.9 | None | 10.1021/jm00115a006 |
| Rattus norvegicus | Rattus norvegicus | Iron output | 196.2 | None | 10.1021/jm00115a006 |
| Rattus norvegicus | Rattus norvegicus | Iron output | 210.7 | None | 10.1021/jm00115a006 |
| Rattus norvegicus | Rattus norvegicus | Iron output | 212.4 | None | 10.1021/jm00115a006 |
| Rattus norvegicus | Rattus norvegicus | Iron output | 219.8 | None | 10.1021/jm00115a006 |
| Rattus norvegicus | Rattus norvegicus | Iron output | 228.4 | None | 10.1021/jm00115a006 |
| Rattus norvegicus | Rattus norvegicus | Iron output | 277.6 | None | 10.1021/jm00115a006 |
| Rattus norvegicus | Rattus norvegicus | Kf | 3.0 | M-1 | 10.1021/jm00036a005 |
| Rattus norvegicus | Rattus norvegicus | Total iron output | 14.7 | ug kg-1 | 10.1021/jm00111a023 |
| Rattus norvegicus | Rattus norvegicus | Total iron output | 16.5 | ug kg-1 | 10.1021/jm00111a023 |
| Rattus norvegicus | Rattus norvegicus | Total iron output | 43.6 | ug kg-1 | 10.1021/jm00111a023 |
| Rattus norvegicus | Rattus norvegicus | Total iron output | 43.9 | ug kg-1 | 10.1021/jm00111a023 |
| Rattus norvegicus | Rattus norvegicus | Total iron output | 49.2 | ug kg-1 | 10.1021/jm00111a023 |
| Rattus norvegicus | Rattus norvegicus | Total iron output | 76.8 | ug kg-1 | 10.1021/jm00111a023 |
| Rattus norvegicus | Rattus norvegicus | Total iron output | 97.1 | ug kg-1 | 10.1021/jm00111a023 |
| Rattus norvegicus | Rattus norvegicus | Total iron output | 105.9 | ug kg-1 | 10.1021/jm00111a023 |
| Rattus norvegicus | Rattus norvegicus | Total iron output | 110.8 | ug kg-1 | 10.1021/jm00111a023 |
| Rattus norvegicus | Rattus norvegicus | Total iron output | 119.8 | ug kg-1 | 10.1021/jm00111a023 |
| Rattus norvegicus | Rattus norvegicus | Total iron output | 128.7 | ug kg-1 | 10.1021/jm00111a023 |
| Rattus norvegicus | Rattus norvegicus | Total iron output | 135.0 | ug kg-1 | 10.1021/jm00111a023 |
| Rattus norvegicus | Rattus norvegicus | Total iron output | 152.8 | ug kg-1 | 10.1021/jm00111a023 |
| Rattus norvegicus | Rattus norvegicus | Total iron output | 173.9 | ug kg-1 | 10.1021/jm00111a023 |
| Rattus norvegicus | Rattus norvegicus | Total iron output | 196.2 | ug kg-1 | 10.1021/jm00111a023 |
| Rattus norvegicus | Rattus norvegicus | Total iron output | 210.7 | ug kg-1 | 10.1021/jm00111a023 |
| Rattus norvegicus | Rattus norvegicus | Total iron output | 219.8 | ug kg-1 | 10.1021/jm00111a023 |
| Rattus norvegicus | Rattus norvegicus | Total iron output | 228.4 | ug kg-1 | 10.1021/jm00111a023 |
| Rattus norvegicus | Rattus norvegicus | Urine/bile | nan | None | 10.1021/jm020184n |
| Sapajus apella | Sapajus apella | Activity | 5.5 | % | 10.1016/j.bmc.2015.06.059 |
| Sapajus apella | Sapajus apella | Activity | 45.0 | % | 10.1016/j.bmc.2015.06.059 |
| Sapajus apella | Sapajus apella | Activity | 55.0 | % | 10.1016/j.bmc.2015.06.059 |
| Severe acute respiratory syndrome coronavirus 2 | Replicase polyprotein 1ab | Inhibition | 8.91 | % | 10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Hit score | -6.19e-05 | None | 10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | IC50 | 19952.62 | nM | 10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | IC50 | 20000.0 | nM | 10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | 0.01 | % | 10.6019/CHEMBL4495565 |
| Trypanosoma brucei | Trypanosoma brucei | FC | 2.0 | None | 10.1016/j.bmc.2012.11.009 |
| Trypanosoma brucei | Trypanosoma brucei | GI50 | 2900.0 | nM | 10.1016/j.bmc.2012.11.009 |
| None | ADMET | CC50 | 400000.0 | nM | 10.1016/j.bmc.2013.08.023 |
| None | ADMET | IC50 | 12050.0 | nM | 10.1021/jm7012562 |
| None | ADMET | Log Pe | -5.3 | cm s-1 | 10.1021/jm001020e |
| None | ADMET | Ratio | nan | None | 10.1016/j.bmc.2011.11.033 |
| None | ADMET | T1/2 | 0.08333 | hr | 10.1016/j.ejmech.2011.01.047 |
| None | Hepatotoxicity | Hepatotoxicity | nan | None | 10.1021/tx900326k |
| None | Hepatotoxicity | HepSE_bilirubinemia | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_cholecystitis | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_cholelithiasis | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_cirrhosis | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_Combined Scores | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_elevated liver function tests | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_hepatic failure | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_hepatic necrosis | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_hepatitis | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_hepatomegaly | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_jaundice | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_liver disease | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_liver fatty | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_liver function tests abnormal | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | LTKB_BD DILI severity score | nan | None | 10.1016/j.drudis.2011.05.007 |
| None | Neutrophil | Inhibition | nan | % | 10.1021/acsmedchemlett.9b00142 |
| None | NON-PROTEIN TARGET | Activity | 80.0 | % | 10.1021/jm900552r |
| None | NON-PROTEIN TARGET | Hepatotoxicity (acute) | 0.0 | % | 10.1016/s0399-8320(04)95062-2 |
| None | NON-PROTEIN TARGET | Hepatotoxicity (animal toxicity known) | nan | None | 10.1016/s0399-8320(04)95062-2 |
| None | NON-PROTEIN TARGET | Hepatotoxicity (benign tumour) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | NON-PROTEIN TARGET | Hepatotoxicity (granulomatous hepatitis) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | NON-PROTEIN TARGET | Hepatotoxicity (mechanism) | nan | None | 10.1016/s0399-8320(04)95062-2 |
| None | NON-PROTEIN TARGET | Hepatotoxicity (moderate) | 1.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | NON-PROTEIN TARGET | Hepatotoxicity (moderate) | 28.0 | % | 10.1016/s0399-8320(04)95062-2 |
| None | NON-PROTEIN TARGET | Hepatotoxicity (time to onset) | nan | None | 10.1016/s0399-8320(04)95062-2 |
| None | NON-PROTEIN TARGET | IC50 | 50000.0 | nM | 10.1016/j.bmc.2009.11.057 |
| None | NON-PROTEIN TARGET | IC50 | 70000.0 | nM | 10.1016/j.bmc.2009.11.057 |
| None | NON-PROTEIN TARGET | Postdrug | 245.0 | ug kg-1 | 10.1021/jm9508752 |
| None | NON-PROTEIN TARGET | Predrug | 217.0 | ug kg-1 | 10.1021/jm9508752 |
| None | No relevant target | Activity | -468.0 | mV | 10.1021/acs.jmedchem.0c01480 |
| None | No relevant target | Activity | 1.0 | % | 10.1021/jm00197a007 |
| None | No relevant target | Activity | 15.0 | % | 10.1016/j.ejmech.2017.08.021 |
| None | No relevant target | Activity | 16.0 | % | 10.1016/j.ejmech.2016.05.015 |
| None | No relevant target | Activity | 25.2 | uM | 10.1021/jm00197a007 |
| None | No relevant target | Activity | 26.6 | None | 10.1021/acs.jmedchem.0c01480 |
| None | No relevant target | Activity | 30.6 | None | 10.1021/jm00197a007 |
| None | No relevant target | Activity | 85.0 | % | 10.1016/j.ejmech.2017.08.021 |
| None | No relevant target | Activity | 93.0 | % | 10.1016/j.ejmech.2016.05.015 |
| None | No relevant target | Activity | nan | None | 10.1016/j.bmcl.2017.03.001 |
| None | No relevant target | Activity | nan | None | 10.1021/acs.jnatprod.1c00155 |
| None | No relevant target | Activity | nan | None | 10.1021/acs.jnatprod.2c00352 |
| None | No relevant target | Distribution coefficient | 0.03 | None | 10.1021/jm00168a033 |
| None | No relevant target | Distribution coefficient | 0.07 | None | 10.1021/jm00168a033 |
| None | No relevant target | IC50 | 4400.0 | nM | 10.1016/j.bmc.2009.11.057 |
| None | No relevant target | IC50 | 5100.0 | nM | 10.1021/acs.jnatprod.6b00051 |
| None | No relevant target | IC50 | 10000.0 | nM | 10.1021/jm070800l |
| None | No relevant target | LogD | -3.0 | None | 10.1021/jm001020e |
| None | No relevant target | LogD7.4 | -3.2 | None | 10.1016/j.bmc.2015.06.059 |
| None | No relevant target | log K | 8.0 | None | 10.1016/j.bmcl.2017.03.001 |
| None | No relevant target | log K | 30.0 | None | 10.1016/j.bmcl.2017.03.001 |
| None | No relevant target | log K | 30.4 | None | 10.1007/s00044-012-0229-1 |
| None | No relevant target | log K | nan | None | 10.1016/j.bmc.2011.11.033 |
| None | No relevant target | LogP | -2.29 | None | 10.1016/j.bmcl.2017.03.001 |
| None | No relevant target | LogP | nan | None | 10.1021/jm9016703 |
| None | No relevant target | Retention_time | -0.52 | min | 10.1016/j.bmcl.2017.03.001 |
| None | No relevant target | Solubility | 400000000.0 | nM | 10.1021/jm9016703 |
| None | Nucleic Acid | Activity | nan | None | 10.1016/j.bmc.2009.04.064 |
| None | Nucleic Acid | Inhibition | nan | % | 10.1021/jm9014394 |
| None | Phospholipidosis | Phospholipidosis | nan | None | 10.1021/ci6004542 |
| None | Phospholipidosis | Phospholipidosis | nan | None | 10.1021/mp100103e |
| None | Unchecked | Activity | 11.0 | % | 10.1021/jm00069a002 |
| None | Unchecked | Activity | 12.0 | % | 10.1021/jm070800l |
| None | Unchecked | Activity | 16.0 | % | 10.1021/jm7012562 |
| None | Unchecked | Activity | 26.6 | None | 10.1016/j.bmc.2012.11.009 |
| None | Unchecked | Activity | 35.0 | None | 10.1021/jm010546b |
| None | Unchecked | Activity | nan | None | 10.1016/j.ejmech.2014.10.067 |
| None | Unchecked | Activity | nan | None | 10.1021/acs.jmedchem.6b00297 |
| None | Unchecked | Activity | nan | None | 10.1021/jm401053m |
| None | Unchecked | Activity | nan | None | 10.1021/np040140c |
| None | Unchecked | Hepatotoxicity (acute) | 1.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (association with vascular disease) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (choleostasis) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (chronic liver disease) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (cirrhosis) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (comment) | nan | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (cytolytic) | 1.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (malignant tumour) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (severe hepatitis) | 1.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (steatosis) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (successful reintroduction) | nan | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Inhibition | 56.0 | % | 10.1021/jm0606342 |
| None | Unchecked | Inhibition | 59.0 | % | 10.1021/jm0606342 |
| None | Unchecked | Inhibition | 60.0 | % | 10.1021/jm0606342 |
| None | Unchecked | Inhibition | 79.0 | % | 10.1021/jm0606342 |
| None | Unchecked | pM | 26.6 | None | 10.1021/jm00197a001 |
| None | Unchecked | Potency | 1412.5 | nM | None |
| None | Unchecked | Potency | 11220.2 | nM | None |
| None | Unchecked | Potency | 12995.3 | nM | None |
| None | Unchecked | Potency | 14125.4 | nM | None |
| None | Unchecked | Potency | 15848.9 | nM | None |
| None | Unchecked | Ratio | 1.0 | None | 10.1021/jm00357a022 |
| None | Unchecked | Ratio CC50/EC50 | 1.0 | None | 10.1016/j.bmc.2013.08.023 |
